Viewing StudyNCT00110266



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00110266
Status: COMPLETED
Last Update Posted: 2021-08-16
First Post: 2005-05-04

Brief Title: Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Iron Overload
Myelodysplastic Syndrome
Keywords:
Name View
Desferal View
ICL670 View
Deferasirox View
Iron chelation View
Chelator View